The U.S. Department of Veterans Affairs Veterans Health Administration awarded a $188,929.02 firm fixed-price delivery order to Triad Isotopes, Inc., a pharmaceutical company specializing in nuclear medicine. The contract is for the delivery of SPECT radiopharmaceuticals to VISN 15 (Veterans Integrated Service Network 15) with no set-aside designation. This award is part of a larger series of contracts between the VA and Triad Isotopes to provide radiopharmaceuticals to VA hospitals nationwide, including prior awards to VISN 1 and VISN 15. The contract period of performance is from October 1, 2018 to September 30, 2019.